Aurea Elizabeth Linder, PhDOctober 2001: Ph.D. in Sciences, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
2002-2006: Postdoctoral, Medical College of Georgia, Augusta, GA.
2006-present: Postdoctoral at the Department of Pharmacology & Toxicology of Michigan State University (Mentor: Dr. Stephanie W. Watts, Ph.D.)
National Heart, Lung, and Blood Institute/ IASH Travel Award from the Inter-American Society of Hypertension, in San Antonio, TX, April 2003.
Award for Excellence in Research from the Medical College of Georgia, in Augusta, GA, January 2005.
ASPET Young Scientist Travel Award from the American Society for Pharmacology and Experimental Therapeutics, in San Diego, CA, April 2005.
ASPET Young Scientist Travel Award from the American Society for Pharmacology and Experimental Therapeutics, in San Francisco, CA, April 2006.
American Heart Association Postdoctoral Fellowship 2006
Selected Publications since 2003
LINDER, AE and BENDHACK, LM: Endothelin-1-induced contraction is impaired in the tail artery of renal hypertensive rats. Vascular Pharmacology 39 (1-2), 77-82, 2002.
JIN, L; LINDER, AE; MILLS, TM and WEBB, RC: Inhibition of the tonic contraction in the treatment of erectile dysfunction. Expert Opinion on Therapeutic Targets, 72 (2): 265-276, 2003.
MILLS, TM; LEWIS, RW; WINGARD, CJ; LINDER, AE; JIN, L and WEBB, RC: Vasoconstriction, RhoA/Rho-kinase and the erectile response. International Journal of Impotence Research 15 (Suppl 5), S20-S24, 2003.
LINDER, AE; McCLUSKEY; LP; LANNING and WEBB, RC: Dynamic association of nitric oxide downstream molecules with the endothelial caveolin-1 in rat aorta. Journal of Pharmacology and Experimental Therapeutics, 314 (1): 9-15, 2005.
LINDER, AE; WEBER, DS; WHITESALL, SE; D’ALECY, LG and WEBB, RC: Altered vascular reactivity in mice made hypertensive by nitric oxide synthase inhibition. Journal of Cardiovascular Pharmacology, 46 (4): 438-444, 2005.
LINDER, AE; WEBB, RC; MILLS, TM; YING, Z; LEWIS RW and TEIXEIRA, CE: Rho-kinase and RGS-containing RhoGEFs as molecular targets for the treatment of erectile dysfunction. Current Pharmaceutical Design, 11 (31): 4029-4040, 2005.
LINDER, AE; LEITE, R; LAURIA, K; MILLS, TM and WEBB, RC:, Penile erection requires the association of soluble guanylyl cyclase with endothelial caveolin-1 in rat corpus cavernosum, submitted to the American Journal of Physiology Regulatory, Integrative and Comparative Physiology, 290 (5): R1302-R1308, 2006.